13F-HR filed by Aisling Capital Management LP
Aisling Capital Management LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-13, with 14 holding rows worth $471,616,868.
- Accession
- 0001766721-26-000003
- Filer
- CIK 1766721
- Filed
- 2026-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 14 entries on the cover page, a total value of $471,616,868 stated on the cover page (in dollars after the unit check, H1), rows summing to $471,616,867 with VALUE read as dollars as filed, 13F file number 028-19070. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 4,589,611 | $341,834,227 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 1,555,664 | $37,647,069 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,316,806 | $28,785,379 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,432,336 | $20,267,554 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 568,919 | $16,891,205 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 1,018,018 | $7,757,297 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 77,031 | $4,236,705 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 108,000 | $3,974,400 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 2,048,757 | $3,011,673 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 434,455 | $2,298,267 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 325,000 | $2,148,250 | dollars as filed | |
| VTV THERAPEUTICS INC | 918385204 | CL A NEW | 50,000 | $1,882,500 | dollars as filed | |
| MARKER THERAPEUTICS INC | 57055L206 | COM NEW | 325,370 | $478,293 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 88,607 | $404,048 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001766721-26-000003 | this filing | 2026-08-13 | acceptance time not in the bulk data set |